About the Company

Cognes is a digital health company developing a smartphone-based cognitive screening and monitoring platform that leverages facial digital biomarkers and machine learning to support earlier detection and monitoring of neurodegenerative diseases.

The company's initial commercial focus is on research and clinical trial environments, where improved patient identification and stratification can enhance trial recruitment, endpoint quality, and operational efficiency.

Current progress includes:

• AI models trained on clinical datasets
• Multicenter pilots across the United States and Europe
• Granted patents in the U.S. and EU
• GDPR- and HIPAA-compliant infrastructure
• Defined roadmap toward future CE Mark and FDA progression

Cognes is positioning itself at the intersection of:

• Digital biomarkers
• Neurodegenerative disease infrastructure
• Cognitive assessment technology
• Clinical research enablement
• AI-powered healthcare innovation

Position

Advisory Board Member

Work Arrangement: Remote

Commitment: Approximately 1–2 Hours per Month

Opportunity Overview

Cognes is assembling a selective Advisory Board composed of senior healthcare, life sciences, medtech, diagnostics, and pharmaceutical leaders.

Advisors will provide strategic guidance as the company transitions from early validation into broader clinical expansion, partnership development, commercialization planning, and long-term scaling initiatives.

This is a strategic advisory role designed for experienced executives who can contribute expertise, industry insight, and executive-level perspective without day-to-day operational responsibilities.

Key Advisory Areas

Clinical Validation & Evidence Strategy

Provide guidance on:

• Clinical validation frameworks
• Evidence generation
• Outcome measurement
• Digital biomarker adoption

Support long-term positioning of the platform within research and clinical environments.

Regulatory & Market Strategy

Advise on:

• Regulatory sequencing
• FDA pathways
• CE Mark progression
• Health Technology Assessment (HTA) considerations

Support strategic positioning within evolving regulatory environments.

Clinical Development

Provide input on:

• Trial design
• Endpoint strategy
• Patient stratification
• Clinical development planning

Help align the platform with evolving clinical research requirements.

Commercial & Partnership Strategy

Advise on:

• Commercial wedge selection
• Market adoption strategy
• Strategic partnerships
• Healthcare ecosystem engagement

Support relationships across:

• Pharmaceutical companies
• CROs
• Healthcare systems
• Diagnostics organizations
• Research institutions

Growth & Scaling

Provide strategic input on:

• Capital strategy
• Business scaling
• Market expansion
• Long-term organizational positioning

Ideal Executive Profiles

Cognes is particularly interested in senior leaders with backgrounds in:

Life Sciences & Healthcare

• Biopharma
• Biotechnology
• CNS-focused organizations
• Digital health
• Diagnostics
• MedTech

Clinical & Regulatory Leadership

• Clinical Development
• Medical Affairs
• Regulatory Affairs
• Clinical Operations
• Market Access
• Health Economics and Outcomes Research (HEOR)

Commercial & Strategic Leadership

• Corporate Development
• Strategic Partnerships
• Licensing
• Commercial Launch Strategy
• Business Development
• Corporate Strategy

Representative Titles

Examples include:

• Chief Medical Officer
• Chief Commercial Officer
• VP Regulatory Affairs
• Global Head of Clinical Development
• CNS Franchise Leader
• Head of Market Access
• VP Medical Affairs
• Corporate Strategy Executive
• Business Development Executive
• Diagnostics Executive
• Managing Director, Life Sciences Advisory
• Executive Director

Board and governance experience is welcomed but not required.

Candidate Note

This is an Advisory Board opportunity rather than a traditional fractional executive engagement. The estimated commitment of approximately 1–2 hours per month makes it particularly attractive for senior healthcare, pharmaceutical, biotech, and medtech leaders seeking strategic advisory involvement.

Candidates should confirm whether compensation includes a cash retainer, equity, equity-linked incentives, meeting fees, or a combination thereof before proceeding.

‍

‍